Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8P0L

Crystal structure of human O-GlcNAcase in complex with an S-linked CKII peptide

Summary for 8P0L
Entry DOI10.2210/pdb8p0l/pdb
DescriptorProtein O-GlcNAcase, CYSTEINE, SERINE, ... (5 entities in total)
Functional Keywordscarbohydrate, s-glcnac, gh84, hydrolase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight206489.27
Authors
Males, A.,Davies, G.J.,Calvelo, M.,Alteen, M.G.,Vocadlo, D.J.,Rovira, C. (deposition date: 2023-05-10, release date: 2023-11-29, Last modification date: 2024-10-16)
Primary citationCalvelo, M.,Males, A.,Alteen, M.G.,Willems, L.I.,Vocadlo, D.J.,Davies, G.J.,Rovira, C.
Human O -GlcNAcase Uses a Preactivated Boat-skew Substrate Conformation for Catalysis. Evidence from X-ray Crystallography and QM/MM Metadynamics.
Acs Catalysis, 13:13672-13678, 2023
Cited by
PubMed Abstract: Human -linked β--acetylglucosaminidase (hOGA) is one of the two enzymes involved in nuclear and cytoplasmic protein O-GlcNAcylation, an essential post-translational modification. The enzyme catalyzes the hydrolysis of the GlcNAc--(Ser/Thr) glycosidic bonds via anchimeric assistance through the 2-acetamido group of the GlcNAc sugar. However, the conformational itinerary of the GlcNAc ring during catalysis remains unclear. Here we report the crystal structure of wild type hOGA in complex with a nonhydrolyzable glycopeptide substrate and elucidate the full enzyme catalytic mechanism using QM/MM metadynamics. We show that the enzyme can bind the substrate in either a chair- or a boat-like conformation, but only the latter is catalytically competent, leading to the reaction products via / → [] → and → [] → / conformational itineraries for the first and second catalytic reaction steps, respectively. Our results reconcile previous experimental observations for human and bacterial OGA and will aid the development of more effective OGA inhibitors for diseases associated with impaired -GlcNAcylation.
PubMed: 37969138
DOI: 10.1021/acscatal.3c02378
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.5 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon